Call Us: (513) 621-5112

Sterling Research Blog
Hypertension: The Silent Killer
Wednesday, October 25, 2017

Hypertension (HTN) or high blood pressure is a very common problem in this country; a leading reason to visit a medical provider and the most frequently prescribed medications. While many health conditions and medications can cause HTN, the majority of patients have primary hypertension. Many people don’t realize they have HTN because there are few if any symptoms unless a lot of damage has been done.

Hypertension is defined as a daytime average blood pressure above 135/85. 135 is your systolic pressure or the pressure exerted on your blood vessels during a heart contraction. 85 is your diastolic pressure or resting pressure in the vascular system between heart beats. The cause of primary HTN is not known but there are risk factors: age, obesity, family history, race, high sodium diet, excessive alcohol intake, physical inactivity, diabetes and high cholesterol. Secondary HTN is caused by medications like: oral contraceptives, NSAIDs (Motrin), steroids, antidepressants, cold medications, weight loss medications and ADHD medications. Some diseases cause HTN as well like: kidney disease, sleep apnea, hypo- or hyper-thyroidism, Cushing’s, pheochromocytoma and others.

Once diagnosed it is important for patient to take their medications regularly. Treatments are individualized to the patient. Most people can be controlled with one medication but some will require two, three or even more. Uncontrolled or poorly controlled HTN is a major risk factor for stroke and heart failure but also chronic kidney disease and heart attacks.

Besides taking your medications consistently, all HTN patients need to make life-style changed to optimize their health. Starting a moderate exercise program with aerobic and muscle-building routines, join a yoga or tai chi class, reduce salt and saturated fat in the diet, limit alcohol intake, lose weight and increase water intake can all help to improve your blood pressure and reduce the need for medications.

Sterling Research will be conducting a study for a new class of blood pressure medications. You could be a medical hero by helping to create a newer and safer medication regimen. To see if you qualify call us at 513-621-5221.

Subscribe To Our Blog

Blog Categories

  • News
  • Articles
    • 10/26/2017 - Are You Concerned About Heart
    • 10/25/2017 - Is Arthritis Pain Holding You
    • 10/25/2017 - Hypertension: The Silent Kille
    • 07/11/2017 - C-Diff: Could a vaccine preven
    • 03/23/2017 - New Drug Prevents Heart Attack
    • 06/07/2016 - Meningitis: More than just a “
    • 02/29/2016 - One Decade Later, HPV Vaccine
    • 05/22/2015 - The Truth About Insulin
    • 05/22/2015 - Diabetes Clinical Research
    • 05/12/2015 - Osteoarthritis
    • 05/04/2015 - What can I do about Acne?
    • 02/18/2015 - Yet Another "Cutting Edge" Med
    • 01/26/2015 - Recent study of an investigati
    • 12/03/2014 - It Is Estimated That 1 in 3 Am
    • 12/02/2014 - Making a positive impact on th
    • 10/28/2014 - Happy Birthday wishes to Dr. J
    • 08/15/2014 - Monoclonal Antibodies Revoluti
    • 07/09/2013 - Swimmer's Ear - What You Need
    • 05/17/2013 - Pink Eye: Usually Mild and Eas
    • 05/05/2013 - High Triglycerides - What You
    • 03/13/2013 - UK Researchers Dispel Myths of
    • 06/14/2012 - Why Do Research In Children?
    • 01/13/2010 - Should Your Child Be in a Clin
    • 05/09/2008 - Med Hero Campaign TV Spot

Tag Cloud

Call For Participation
Patient Recruitment Specialist
Cincinnati, OH

PH: (513) 621-5112
FX:  (513) 621-5101

Cincinnati / Mt. Auburn
2230 Auburn Avenue
Level B
Cincinnati, OH 45219
PH: (513) 381-4100
FX:  (513) 381-4120

375 Glensprings Drive
2nd Floor
Cincinnati, OH 45246
PH: (513) 671-8080
FX:  (513) 671-8090
Are You Concerned About Heart Failure?
Thursday, October 26, 2017

Congestive heart failure is a common cardiac problem in the US.  After age 40, 1 in 5 people will develop some form of heart failure and the risk increases as we age.  


Copyright © 2019. STERLING RESEARCH. All Rights Reserved